What is the best way to deliver therapeutics and who decides?

Author： Tucker Ian G   Norris Pauline T   Duffull Stephen B  

Publisher： Future Science

ISSN： 2041-5990

Source： Therapeutic Delivery, Vol.4, Iss.7, 2013-07, pp. : 763-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology

By Chistiakov Dimitry A.   Sobenin Igor A.   Orekhov Alexander N.  

Drug Delivery, Vol. 19, Iss. 8, 2012-11 ,pp. : 392-405

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics, Pharmacogenomics, and Cardiovascular Therapeutics: The Way Forward

By Terra S.G.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 5, 2002-01 ,pp. : 287-296

Adis International

Access to resources Recommend Favorite

WHO strategy proves best for PMTCT of HIV in Nigeria . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 628, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Women who deliver via caesarean section incur greater healthcare costs than those

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

What's the next best cytokine target in IBD?

By MacDonald Thomas T.   Biancheri Paolo   Sarra Massimiliano   Monteleone Giovanni  

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2180-2189

Blackwell Publishing

Access to resources Recommend Favorite